For so long the US healthcare system was built around the provider, with appointments and services set by the provider (along with insurance reimbursement systems).
In this week’s pharmaphorum digital health round-up we look at Akili’s therapeutic video game, the unveiling of next-gen medical imaging tech by NVIDIA, a new blockcha
After two FDA rejections for non-alcoholic steatohepatitis (NASH) therapy obeticholic acid (OCA), Intercept Pharma has agreed to be taken over by Italian drugmaker Alfasig
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho
